Five PK metrics + S×F interaction [Regulatives / Guidelines]
Dear Kumar,
Thanks for sharing the revised guidance.
As Mr Helmut rightly said, they are asking for additional partial AUCs which will be difficult to match and suggested to estimate subject-by-formulation interaction..!
Will this subject-by-formulation estimation applies for other Bimodal release formulations too.?
Thanks for sharing the revised guidance.
As Mr Helmut rightly said, they are asking for additional partial AUCs which will be difficult to match and suggested to estimate subject-by-formulation interaction..!
Will this subject-by-formulation estimation applies for other Bimodal release formulations too.?

—
Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn
Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn
Complete thread:
- Draft FDA guidance on Methylphenidate Hydrochloride kumarnaidu 2014-11-10 08:16 [Regulatives / Guidelines]
- Five PK metrics + S×F interaction Helmut 2014-11-10 13:57
- Five PK metrics + S×F interaction AngusMcLean 2014-11-11 19:26
- Five PK metrics + S×F interaction jag009 2014-11-16 03:39
- Acceptance limit for the upper 95% confidence bound? Helmut 2014-11-17 12:49
- Acceptance limit for the upper 95% confidence bound? jag009 2014-11-17 17:29
- Quoting László Helmut 2014-11-18 03:56
- Acceptance limit for the upper 95% confidence bound? AngusMcLean 2014-11-19 13:28
- Acceptance limit for the upper 95% confidence bound? jag009 2014-11-17 17:29
- Acceptance limit for the upper 95% confidence bound? Helmut 2014-11-17 12:49
- Five PK metrics + S×F interaction kumarnaidu 2014-12-09 08:36
- Five PK metrics + S×F interactiondrgunasakaran1 2014-11-10 18:29
- Five PK metrics + S×F interaction jag009 2014-11-11 18:04
- Five PK metrics + S×F interaction AngusMcLean 2014-11-11 19:22
- Five PK metrics + S×F interaction jag009 2014-11-11 20:08
- Tada! jag009 2014-11-13 20:17
- Tada! AngusMcLean 2014-11-13 23:06
- Tada! nobody 2014-11-19 09:30
- Tada! AngusMcLean 2014-11-19 13:42
- Tada! nobody 2014-11-19 13:55
- ABEL Helmut 2014-11-19 15:44
- ABEL nobody 2014-11-19 16:05
- ABEL Helmut 2014-11-19 16:59
- ABEL nobody 2014-11-19 17:10
- ABEL Helmut 2014-11-19 17:16
- ABEL AngusMcLean 2014-11-19 17:45
- Difficult formulations Helmut 2014-11-19 20:15
- Difficult formulations nobody 2014-11-19 21:04
- Difficult formulations Helmut 2014-11-19 21:49
- Difficult formulations nobody 2014-11-19 21:04
- Difficult formulations Helmut 2014-11-19 20:15
- ABEL nobody 2014-11-19 17:10
- ABEL Helmut 2014-11-19 16:59
- ABEL nobody 2014-11-19 16:05
- ABEL Helmut 2014-11-19 15:44
- Tada! nobody 2014-11-19 13:55
- Tada! AngusMcLean 2014-11-19 13:42
- Tada! nobody 2014-11-19 09:30
- Tada! AngusMcLean 2014-11-13 23:06
- Tada! jag009 2014-11-13 20:17
- Five PK metrics + S×F interaction jag009 2014-11-11 20:08
- Five PK metrics + S×F interaction Helmut 2014-11-10 13:57
